Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 281

Similar articles for PubMed (Select 18472359)

1.

Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma.

Shinohara ET, Mitra N, Guo M, Metz JM.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1495-501. doi: 10.1016/j.ijrobp.2008.03.018. Epub 2008 May 28.

PMID:
18472359
2.

Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas.

Shinohara ET, Mitra N, Guo M, Metz JM.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1191-8. doi: 10.1016/j.ijrobp.2008.09.017. Epub 2009 Feb 7.

PMID:
19201549
3.

Brachytherapy in the treatment of cholangiocarcinoma.

Shinohara ET, Guo M, Mitra N, Metz JM.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):722-8. doi: 10.1016/j.ijrobp.2009.08.070. Epub 2010 Mar 6.

PMID:
20207503
4.

Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.

Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, Crane CH, Talamonti MS, Munoz LL, Small W Jr.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):189-98. doi: 10.1016/j.ijrobp.2010.05.001. Epub 2010 Oct 23.

PMID:
20971573
5.

Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.

Sagawa N, Kondo S, Morikawa T, Okushiba S, Katoh H.

Surg Today. 2005;35(7):548-52.

PMID:
15976951
6.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
7.
8.

Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.

Kao J, Lavaf A, Teng MS, Huang D, Genden EM.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):362-70. doi: 10.1016/j.ijrobp.2007.09.058. Epub 2007 Dec 31.

PMID:
18164833
9.

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR.

Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3.

PMID:
18580211
10.

Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.

Shaib YH, Davila JA, Henderson L, McGlynn KA, El-Serag HB.

J Clin Gastroenterol. 2007 Nov-Dec;41(10):911-7.

PMID:
18090160
11.

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL.

Ann Surg. 1995 Jun;221(6):788-97; discussion 797-8.

12.

Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.

Kaiser GM, Frühauf NR, Lang H, Sauerwein W, Sotiropoulos GC, Zöpf T, Grabellus F, Wittig A, Oldhafer KJ, Malagó M, Broelsch CE.

Hepatogastroenterology. 2008 Nov-Dec;55(88):1951-4.

PMID:
19260456
13.

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.

Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.

Gynecol Oncol. 2009 Sep;114(3):442-7. doi: 10.1016/j.ygyno.2009.06.005. Epub 2009 Jun 26.

PMID:
19560193
14.

External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.

Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):772-9.

PMID:
17011452
15.

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Stessin AM, Meyer JE, Sherr DL.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128-33. doi: 10.1016/j.ijrobp.2008.02.065. Epub 2008 Jun 4.

PMID:
18538501
16.

[Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].

Kim W, Lee JH, Kim YJ, Yoon JH, Suh KS, Lee KU, Jang JJ, Lee HS.

Korean J Gastroenterol. 2007 Mar;49(3):158-65. Korean.

17.

Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.

Gwak HK, Kim WC, Kim HJ, Park JH.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):194-8. doi: 10.1016/j.ijrobp.2009.07.003. Epub 2009 Nov 10.

PMID:
19910130
18.

Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.

Fuller CD, Wang SJ, Choi M, Czito BG, Cornell J, Welzel TM, McGlynn KA, Luh JY, Thomas CR Jr.

Cancer. 2009 Nov 15;115(22):5175-83. doi: 10.1002/cncr.24572.

19.

Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival.

Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M.

Eur J Surg Oncol. 2007 Mar;33(2):202-7. Epub 2006 Nov 7.

PMID:
17088040
20.

Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.

Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM, Guy SR, Sheiner PA, Miller CM, Schwartz ME.

J Am Coll Surg. 1998 Oct;187(4):365-72.

PMID:
9783782
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk